Ellie

Ellie is a week‑by‑week educational companion designed for people who have used GLP‑1 medications (such as Wegovy, Ozempic, Mounjaro, Zepbound) and want to maintain their weight loss during, while tapering, or after stopping the drug.

• Provides a personalized After Plan that predicts water‑weight jumps, appetite return, and high‑risk windows.
• Features a Food Noise SOS tool, protein and strength floor targets, and a trend line that watches a 7‑day average to catch drift at 4 lb instead of 20 lb.
• Offers free tools (washout calculator, microdosing chart, taper visualizer, maintenance calories, protein calculator) and 26 evidence‑based guides.
• Exports a one‑page summary for discussions with prescribers, never suggesting doses.
• Available now on iOS (Android coming), free to download with a subscription unlocking the full plan.

Target audience: individuals on GLP‑1 therapy seeking structured support to prevent regain; clinicians looking for a data‑based companion to share with patients.

Value proposition: turns research on discontinuation into actionable weekly guidance, reducing the average 2/3 weight regain by giving users architecture, not willpower.